ADVERTISEMENT
Video
Stopping GLP-1 medications doubles risk of major heart events: study
A new European study suggests that Type 2 diabetes patients who stop taking popular GLP-1 medications face twice the risk of a major cardiac event.
ADVERTISEMENT
A new European study suggests that Type 2 diabetes patients who stop taking popular GLP-1 medications face twice the risk of a major cardiac event.